Paradigm Biopharmaceuticals Ltd (PAR) - Total Liabilities

Latest as of December 2025: AU$17.16 Million AUD ≈ $12.14 Million USD

Based on the latest financial reports, Paradigm Biopharmaceuticals Ltd (PAR) has total liabilities worth AU$17.16 Million AUD (≈ $12.14 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Paradigm Biopharmaceuticals Ltd net asset momentum to track the company's year-over-year net asset growth rate.

Paradigm Biopharmaceuticals Ltd - Total Liabilities Trend (2014–2025)

This chart illustrates how Paradigm Biopharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data.

Paradigm Biopharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Paradigm Biopharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Dogusan Boru Sanayi ve Ticaret AS IS:DOGUB	Turkey	TL5.03 Million
Hoffmann Green Cement Technologies PA:ALHGR	France	€44.23 Million
Talenom Oyj HE:TNOM	Finland	€129.23 Million
kenturn Nano Tec Co Ltd TWO:4561	Taiwan	NT$859.47 Million
Newcore Gold Ltd V:NCAU	Canada	CA$3.64 Million
Space Shuttle Hi-Tech Co Ltd TW:2440	Taiwan	NT$1.28 Billion
Grupo Mexicano de Desarrollo S.A.B MX:GMD	Mexico	MX$3.96 Billion
Amoeba SA PA:ALMIB	France	€15.49 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Paradigm Biopharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PAR market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.31	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.86	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.74	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Paradigm Biopharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Paradigm Biopharmaceuticals Ltd (2014–2025)

The table below shows the annual total liabilities of Paradigm Biopharmaceuticals Ltd from 2014 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$3.39 Million ≈ $2.40 Million	-5.49%
2024-06-30	AU$3.58 Million ≈ $2.54 Million	-73.23%
2023-06-30	AU$13.39 Million ≈ $9.48 Million	+59.88%
2022-06-30	AU$8.38 Million ≈ $5.93 Million	+28.49%
2021-06-30	AU$6.52 Million ≈ $4.61 Million	+55.88%
2020-06-30	AU$4.18 Million ≈ $2.96 Million	+54.62%
2019-06-30	AU$2.70 Million ≈ $1.91 Million	+103.80%
2018-06-30	AU$1.33 Million ≈ $939.01K	+38.92%
2017-06-30	AU$955.29K ≈ $675.93K	-14.45%
2016-06-30	AU$1.12 Million ≈ $790.13K	+93.42%
2015-06-30	AU$577.33K ≈ $408.49K	+56.60%
2014-06-30	AU$368.67K ≈ $260.85K	--

About Paradigm Biopharmaceuticals Ltd

AU:PAR Australia Biotechnology

Market Cap

$66.92 Million

AU$94.58 Million AUD

Market Cap Rank

#20785 Global

#702 in Australia

Share Price

AU$0.18

Change (1 day)

-5.26%

52-Week Range

AU$0.14 - AU$0.45

All Time High

AU$4.35